TFA
TGTX icon

Toth Financial Advisory’s TG Therapeutics TGTX Stock Holding History

Toth Financial Advisory’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$3.61K – 984
2025
Q3 		$3.61K Hold
100
– – ﹤0.01% 647
2025
Q2 		$3.6K Buy
+100
New +$3.72K ﹤0.01% 584
2021
Q3 		– Sell
-40
Closed -$2K – 794
2021
Q2 		$2K Buy
+40
New +$1.57K ﹤0.01% 617

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Toth Financial Advisory's TGTX Position: Q4 2025 in Review

Toth Financial Advisory sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 100 shares — an estimated $3.61K sold.

Toth Financial Advisory first reported a position in TGTX in Q2 2021 and held it in 3 quarters. The position peaked at $3.61K in Q3 2025. 352 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Toth Financial Advisory reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 100 TG Therapeutics shares in Q4 2025, an estimated $3.61K.
  • Toth Financial Advisory first reported a position in TG Therapeutics in Q2 2021 and held it in 3 quarters.
  • Toth Financial Advisory's TG Therapeutics position peaked at $3.61K in Q3 2025.
  • 352 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Toth Financial Advisory's 13F filing for Q4 2025, filed 20 Jan 2026.